China Cord Blood beats by $0.01, revenue in-line

|About: China Cord Blood Corporation (CO)|By:, SA News Editor

China Cord Blood (NYSE:CO): FQ1 EPS of $0.06 beats by $0.01.

Revenue of $24.71M (+18.0% Y/Y) in-line.